Kartik Kiran Shah
Fondatore presso Oxeia Biopharmaceuticals, Inc.
Profilo
Kartik Kiran Shah is the founder of Oxeia Biopharmaceuticals, Inc. (founded in 2014) where he holds the title of Director.
He is currently the Chairman-Trustees Board at Global X Funds.
In his former positions, he served as Director-Consulting & Product Management at Wireless Generation, Inc., Manager at Amgen, Inc., Principal at Medtronic, Inc., Vice President-Business Development at LungLife AI, Inc., and Management Consultant at Oliver, Wyman & Co. LLC.
Mr. Shah obtained his undergraduate degree from the University of Pennsylvania and his MBA from Harvard Business School.
Posizioni attive di Kartik Kiran Shah
| Società | Posizione | Inizio |
|---|---|---|
| Global X Funds | Direttore/Membro del Consiglio | - |
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Fondatore | 01/01/2014 |
Precedenti posizioni note di Kartik Kiran Shah
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Wireless Generation, Inc.
 Wireless Generation, Inc. Packaged SoftwareTechnology Services Wireless Generation develops software tools, systems and services for teachers. It offers technology that analyzes student data and provides curriculum customized to individual learning needs. The company also builds large-scale data systems, such as New York City's ARIS, that centralize student data and give educators and parents visibility into learning | Corporate Officer/Principal | - |
| Oliver, Wyman & Co. LLC | Corporate Officer/Principal | - |
| LUNGLIFE AI, INC. | Corporate Officer/Principal | - |
Formazione di Kartik Kiran Shah
| Harvard Business School | Masters Business Admin |
| University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LUNGLIFE AI, INC. | Health Services |
| AMGEN INC. | Health Technology |
| Aziende private | 5 |
|---|---|
| Global X Funds | Miscellaneous |
Wireless Generation, Inc.
Wireless Generation, Inc. Packaged SoftwareTechnology Services Wireless Generation develops software tools, systems and services for teachers. It offers technology that analyzes student data and provides curriculum customized to individual learning needs. The company also builds large-scale data systems, such as New York City's ARIS, that centralize student data and give educators and parents visibility into learning | Technology Services |
| Oliver, Wyman & Co. LLC | |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Kartik Kiran Shah
